Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
British Medical Journal
These effects, when present, are typically manageable and resolve with continued use or dose adjustment
The Phase 2 trial results Published in the New England Journal of Medicine, the Phase 2 trial showed that participants receiving the highest dose of retatrutide (12mg weekly) achieved a mean weight reduction of 24.2% at 48 weeks
Our vitamin B12 injections can help improve your mental and physical health Dont wait any longer, book your appointment now to start your journey towards improved mental and physical health.
Phase 2 trial data (Jastreboff et al., NEJM 2023) demonstrated average weight reductions of approximately 1724% over 48 weeks notably higher than currently approved GLP-1 receptor agonists such as semaglutide, though direct comparisons are limited by differences in trial populations and designs
US$ 29.76
US$ 22.37
US$ 22.60
US$ 20.72
